Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening
NCT ID: NCT00977392
Last Updated: 2013-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3000 participants
OBSERVATIONAL
2009-06-30
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This randomized clinical trial is studying self-sampling in women who do not undergo routine cervical screening.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To ascertain whether women who do not attend for cervical screening are more likely to respond to the opportunity to collect a self-sample for human papillomavirus (HPV) testing, or to respond to a further invitation to undergo a cervical smear.
* To ascertain whether such women will attend for further investigation if they have a positive screening test (HPV test or cervical smear).
OUTLINE: Patients are randomized to 1 of 2 arms.
* Control: Patients receive an invitation for a routine cervical smear and a cervical screening survey. Information regarding attendance for smear or colposcopy is collected at the Primary Care Trust.
* Study (self-sampling kit): Patients receive an explanatory letter, an information sheet about the study, a consent form, information about human papillomavirus (HPV) and HPV testing, a self-sampling test kit, and an invitation to take their own HPV sample and return it to the research group for processing. Patients also receive a cervical screening survey. Patients who attend for further investigation following a positive HPV result go to St. Mary's Hospital Colposcopy Unit, Paddington. During this visit cervical smear tests are performed and women are offered immediate colposcopy so that they would not need to return for colposcopic examination if their smear test is abnormal.
This study is peer reviewed and funded or endorsed by cancer research UK.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
compliance monitoring
cervical Papanicolaou test
educational intervention
screening questionnaire administration
survey administration
colposcopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No women who are not due for routine screening as part of the NHSCSP
PATIENT CHARACTERISTICS:
* Not pregnant
* Have been sexually active
PRIOR CONCURRENT THERAPY:
* No prior total abdominal hysterectomy
25 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barts and the London School of Medicine and Dentistry
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Szarewski, MD
Role: PRINCIPAL_INVESTIGATOR
Queen Mary University of London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barts and the London School of Medicine
London, England, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer. 2011 Mar 15;104(6):915-20. doi: 10.1038/bjc.2011.48. Epub 2011 Feb 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDR0000648274
Identifier Type: REGISTRY
Identifier Source: secondary_id
ISRCTN40182307
Identifier Type: REGISTRY
Identifier Source: secondary_id
EU-20963
Identifier Type: -
Identifier Source: secondary_id
CRUK-Westminster-Self-Sampling
Identifier Type: -
Identifier Source: org_study_id